Get complete access to comprehensive company data for Stemrx Bioscience Solutions Private Limited.
Complete Report
One-time • Full access
Credit Plan
Pay as you go • Instant
Processing your request...
Downloading your report...
Success
Request Company Screening
Stemrx Bioscience Solutions Private Limited
Once your screening request is processed, you will receive a notification and the complete report will be available in PDF format for download from your account dashboard.
₹ 0.02 cr
₹ 0.01 cr
13 Feb 2014
31 Mar 2023
Stemrx Bioscience Solutions Private Limited is an Indian private limited company incorporated on 13 Feb 2014. The company's registered office is situated in Thane, Maharashtra, India.
The current status of Stemrx Bioscience Solutions Private Limited is Active. The company has filed its annual returns and financial statements up to 31 Mar 2023 (FY 2022-2023).
Stemrx Bioscience Solutions Private Limited is a company limited by shares with an authorized capital of ₹0.02 cr and a paid-up capital of ₹0.01 cr as per the records maintained by the Ministry of Corporate Affairs (MCA).
Stemrx Bioscience Solutions Private Limited has 3 directors. The directors of the company include Neetin Shivajirao Desai, Pradeep Venkatrao Mahajan, Vipula Pradeep Mahajan.
The registered office of Stemrx Bioscience Solutions Private Limited is located at First Floor, R-831, Dr. Mahajan Hospital, T T C Rabale, Thane Belapur Rd. Navi Mumbai Maharashtra 400708 India in Thane, Maharashtra, India.
- CIN/LLPIN/FCRN: U93030MH2014PTC253238
- Legal Name: Stemrx Bioscience Solutions Private Limited
- ROC Code: Roc Mumbai
- Company No.: 253238
- Company Category: Company Limited By Shares
- Company Sub Category: Non-Government Company
- Company Class: Private
- Listing Status: Unlisted
- Industry: -
- Date of AGM: 28 Sep 2023
🔒 14.3%
(FY 202_)🔒 8.9%
(FY 202_)🔒 12.7%
(FY 202_)🔒 9.5%
(FY 202_)🔒 11.8%
(FY 202_)🔒 15.2%
(FY 202_)🔒 10.6%
(FY 202_)🔒 13.4%
(FY 202_)
Financial Performance Overview
| Financial Metric | FY 2023 | Growth | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | 12,45,67,890 | +191.42% | 4,26,78,123 | 3,89,45,234 | 2,98,12,456 | 2,15,67,890 |
| Revenue from Operations | 11,98,45,678 | +176.82% | 4,32,10,987 | 3,78,90,123 | 2,89,45,678 | 2,10,23,456 |
| Total Assets | 45,67,89,012 | +61.07% | 28,34,56,789 | 24,56,78,901 | 19,87,65,432 | 16,54,32,109 |
| Profit or Loss | -1,23,45,678 | 24.56% | 4,32,109 | 2,15,678 | 1,89,234 | 1,23,456 |
| Net Worth | 12,34,56,789 | 85.66% | 85,67,89,012 | 78,90,12,345 | 65,43,21,098 | 54,32,10,987 |
| EBITDA | 2,34,56,789 | +6604.87% | 3,49,012 | 2,10,987 | 1,56,789 | 98,765 |
| Past Director Details of Stemrx Bioscience Solutions Private Limited |
|---|
Frequently Asked Questions
- neetin shivajirao desai
- pradeep venkatrao mahajan
- vipula pradeep mahajan